These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1715763)

  • 21. Release of immunoreactive human neutrophil proteinase 4, normally and in peritonitis.
    Lundberg E; Bergenfeldt M; Ohlsson K
    Scand J Clin Lab Invest; 1991 Feb; 51(1):23-9. PubMed ID: 1708522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neutrophil elastase potentiates cathepsin G-induced platelet activation.
    Selak MA
    Thromb Haemost; 1992 Nov; 68(5):570-6. PubMed ID: 1333649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of properties of membrane bound versus soluble forms of human leukocytic elastase and cathepsin G.
    Bangalore N; Travis J
    Biol Chem Hoppe Seyler; 1994 Oct; 375(10):659-66. PubMed ID: 7888078
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutants of plasminogen activator inhibitor-1 designed to inhibit neutrophil elastase and cathepsin G are more effective in vivo than their endogenous inhibitors.
    Stefansson S; Yepes M; Gorlatova N; Day DE; Moore EG; Zabaleta A; McMahon GA; Lawrence DA
    J Biol Chem; 2004 Jul; 279(29):29981-7. PubMed ID: 15131125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G.
    Janusz MJ; Doherty NS
    J Immunol; 1991 Jun; 146(11):3922-8. PubMed ID: 2033261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cytosolic inhibitor of human neutrophil elastase and cathepsin G.
    Thomas RM; Nauseef WM; Iyer SS; Peterson MW; Stone PJ; Clark RA
    J Leukoc Biol; 1991 Dec; 50(6):568-79. PubMed ID: 1658173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G.
    Okada Y; Nakanishi I
    FEBS Lett; 1989 Jun; 249(2):353-6. PubMed ID: 2544455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L.
    Goretzki L; Schmitt M; Mann K; Calvete J; Chucholowski N; Kramer M; Günzler WA; Jänicke F; Graeff H
    FEBS Lett; 1992 Feb; 297(1-2):112-8. PubMed ID: 1551416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-bound elastase of neutrophil extracellular traps degrades plasminogen, reduces plasmin formation, and decreases fibrinolysis: proof of concept in septic shock plasma.
    Cruz DBD; Helms J; Aquino LR; Stiel L; Cougourdan L; Broussard C; Chafey P; Riès-Kautt M; Meziani F; Toti F; Gaussem P; Anglés-Cano E
    FASEB J; 2019 Dec; 33(12):14270-14280. PubMed ID: 31682515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific sensitivity of CD43 to neutrophil elastase.
    Remold-O'Donnell E; Parent D
    Blood; 1995 Sep; 86(6):2395-402. PubMed ID: 7662987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active site mapping of the serine proteases human leukocyte elastase, cathepsin G, porcine pancreatic elastase, rat mast cell proteases I and II. Bovine chymotrypsin A alpha, and Staphylococcus aureus protease V-8 using tripeptide thiobenzyl ester substrates.
    Harper JW; Cook RR; Roberts CJ; McLaughlin BJ; Powers JC
    Biochemistry; 1984 Jun; 23(13):2995-3002. PubMed ID: 6380580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin.
    Scuderi P; Nez PA; Duerr ML; Wong BJ; Valdez CM
    Cell Immunol; 1991 Jul; 135(2):299-313. PubMed ID: 2036673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neutrophil elastase and cathepsin G: structure, function, and biological control.
    Watorek W; Farley D; Salvesen G; Travis J
    Adv Exp Med Biol; 1988; 240():23-31. PubMed ID: 3266707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human eosinophils lack human leukocyte elastase.
    Wiedow O; Muhle K; Streit V; Kameyoshi Y
    Biochim Biophys Acta; 1996 Apr; 1315(3):185-7. PubMed ID: 8611657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibition of human neutrophil elastase and cathepsin G by peptidyl 1,2-dicarbonyl derivatives.
    Mehdi S; Angelastro MR; Burkhart JP; Koehl JR; Peet NP; Bey P
    Biochem Biophys Res Commun; 1990 Jan; 166(2):595-600. PubMed ID: 2302225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutrophil cathepsin G promotes prothrombinase and fibrin formation under flow conditions by activating fibrinogen-adherent platelets.
    J Biol Chem; ; . PubMed ID: 12524437
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.